New EGAPP Recommendation: Genomic Testing to Assess Type 2 Diabetes Risk

Genomics|Update|Current

New EGAPP Recommendation: Genomic Testing to Assess Type 2 Diabetes Risk

• New recommendation from the EGAPP working group: Does genomic profiling to assess type 2 diabetes risk improve health outcomes? Genet Med advance online publication, Mar 14


• EGAPP review: Use of genomic panels to determine risk of developing type 2 diabetes in the general population: a targeted evidence-based review Glenn E. Palomaki et al. Genet Med advance online publication, Mar 14


• CDC fact sheet: Identifying opportunities for using genomic information and family history to improve health and transform healthcare  [PDF 1.04 MB]